TICKERNERD
Menu
AVAHAVAHHealthcare · Medical Care Facilities

AVAH Stock Forecast: Aveanna Healthcare Holdings, Inc. Price Predictions for 2026-2027

Last close, 8 Sept 2026
$14
+0.59% on the day

The 11 Wall Street analysts covering Aveanna Healthcare Holdings, Inc. hold a median 12-month price target of $15 — +6.1% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 87 of 100 as at 7 Sept 2026 — inside the top quartile. Here, the model and the Street point the same way.

Market cap
$3.0B
Ticker Nerd rank
87 / 100
Median analyst target
$15
Analysts covering
11
Revenue$670.5M+13.7% y/y
Operating income$84.4M
Net income$40.3M
Free cash flow$79.6M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
+1.8%
1M
+43.9%
YTD
+67.2%
1Y
+65.4%
From 52W high
−1.2%
From 52W low
+119.6%
$6
$14
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

AVAH stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Aveanna Healthcare Holdings, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 7 Sept 2026
87 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Momentum
99
Revisions
96
Quality
91
Growth
89
Value
70
Volatility
32
Issuance
32
Size
31
Accruals
23

Momentum (99): The shares have been drifting up relative to others.

Accruals (23): A large share of reported profit has not shown up as cash, or the balance sheet is expanding quickly — both tend to unwind.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

AVAH stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on AVAH, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$6$8$10$12$14$16Oct 25Jan 26Apr 26Jul 26AVAHHigh $16Median $15Low $8

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says11 analysts
8 Buy3 Hold0 Sell
Low $8Median $15High $16

The green dot is the last close — the median target sits +6.1% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 8 moved their price target up and 0 moved it down.

DateFirmActionRatingTarget
28 Aug 2026BarclaysMaintainsOverweight$9.50 → $15
24 Aug 2026RBC CapitalMaintainsOutperform$10 → $16
24 Aug 2026Truist SecuritiesMaintainsHold$11 → $15
14 Aug 2026BMO CapitalMaintainsOutperform—
14 Aug 2026BMO CapitalMaintainsOutperform$10 → $14
14 Aug 2026Raymond JamesMaintainsStrong Buy—
14 Aug 2026Raymond JamesMaintainsStrong Buy$13 → $15
14 Aug 2026UBSMaintainsNeutral$8.00 → $13
14 Aug 2026UBSMaintainsNeutral—
14 July 2026Truist SecuritiesMaintainsHold—
14 July 2026Truist SecuritiesMaintainsHold$9.00 → $11
9 July 2026BarclaysMaintainsOverweight$9.00 → $9.50
9 July 2026BarclaysMaintainsOverweight—
3 June 2026RBC CapitalUpgradeOutperform—
20 May 2026Truist SecuritiesMaintainsHold—
18 May 2026BarclaysMaintainsOverweight—
15 May 2026RBC CapitalMaintainsSector Perform—
15 May 2026Stephens & Co.UpgradeOverweight—
13 Apr 2026Truist SecuritiesMaintainsHold—
25 Mar 2026BarclaysMaintainsOverweight—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. AVAH appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

AVAH vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 8 Sept 2026, Aveanna Healthcare Holdings, Inc. returned +65.4% against +19.4% for the S&P 500, dividends included.

AVAH vs S&P 500, last 12 monthsTotal return, rebased to 100
80100120140160180Oct 25Jan 26Apr 26Jul 26AVAHS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

AVAH analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
+20.5%
Analysts raising
10
Analysts cutting
0
Fundamentals

Aveanna Healthcare Holdings, Inc. (AVAH) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
10.8×

Cheaper than 57% of US stocks

Price / sales
1.1×

Cheaper than 67% of US stocks

Price / book
10.3×

Cheaper than 10% of US stocks

EV / EBITDA
14.0×

Cheaper than 26% of US stocks

Growth & margins
Revenue growth (YoY)
13.7%

Higher than 60% of US stocks

Earnings growth (YoY)
49.1%

Higher than 74% of US stocks

Gross margin
32.6%

Higher than 38% of US stocks

Operating margin
12.6%

Higher than 68% of US stocks

Net margin
10.6%

Higher than 71% of US stocks

Returns & dividend
Return on equity
198.6%

Higher than 98% of US stocks

Return on assets
9.7%

Higher than 91% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Aveanna Healthcare Holdings, Inc. (AVAH) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Aveanna Healthcare Holdings, Inc. has a market value of $3.0B and an enterprise value of $4.4B.

  • Revenue in the twelve months to 30 June 2026: $2.6B. The latest quarter grew 13.7% year on year.

  • Net income over the same four quarters: $274.8M, a 10.6% net margin.

  • Diluted earnings per share, trailing twelve months: $1.23.

  • Free cash flow in the twelve months to 30 June 2026: $158.4M.

  • Shares outstanding: 218.2M.

  • Trailing P/E: 10.8×; forward P/E: 15.1× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Aveanna Healthcare Holdings, Inc. employs 3,500 people — $744K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 8 Sept 2026

Data provided by Twelve Data

Peers

AVAH vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Care Facilities
CompanyMarket capTKN rank
AVAHAveanna Healthcare Holdings, Inc.$3.0B
87
BKDBrookdale Senior Living, Inc.$2.8B
77
ACHCAcadia Healthcare Co., Inc.$2.6B
57
GRDNGuardian Pharmacy Services, Inc.$2.6B
82
NHCNational HealthCare Corp.$3.4B
67
OPCHOption Care Health, Inc.$3.8B
84
MDPediatrix Medical Group, Inc.$2.2B
99

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Aveanna Healthcare Holdings, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest AVAH news & analysis

Stock Picks From Seeking Alpha's August 2026 New Analysts

Seeking Alpha · 8 Sept 2026neutral

Seeking Alpha welcomed 25 new analysts in August 2026 and showcased their stock picks and investment strategies, with ratings ranging from Strong Sell to Strong Buy. Bullish theses were presented for CTO Realty, Allogene Therapeutics, NanoXplore, Modine, and 3i Group; Aveanna Healthcare Holdings is not mentioned.

Why it matters — AVAH watchers may note that the company was not highlighted or referenced in this analyst coverage, so the item carries no direct implications for Aveanna's outlook.

Is Aveanna Healthcare (AVAH) Stock Undervalued Right Now?

Zacks Investment Research · 3 Sept 2026neutral

Zacks Investment Research published an analysis questioning whether Aveanna Healthcare (AVAH) stock is currently undervalued, discussing its focus on its Zacks Rank system which emphasizes earnings estimates and estimate revisions, while also noting its attention to value, growth, and momentum trends.

Why it matters — An AVAH watcher would care because this piece evaluates the stock's potential valuation status using Zacks' widely followed ranking methodology, providing insight into how the company is assessed by a prominent research firm.

Aveanna Healthcare: Increasing Earnings And Delevering Focus Make It An Appealing Stock

Seeking Alpha · 31 Aug 2026positive

A Seeking Alpha article highlights Aveanna Healthcare's strong revenue and earnings growth, driven by its focus on private duty services and strategic M&A. Despite high leverage reflected in a low LTM P/E of 11.8x, management is prioritizing cash-funded acquisitions and disciplined expansion to reduce leverage below 3x.

Why it matters — AVAH watchers would care because the article underscores the company's growth trajectory and its debt-reduction plan, which directly relates to its balance-sheet risk and valuation relative to peers.

4 Outpatient & Home Healthcare Stocks in Focus Amid Industry Tailwinds

Zacks Investment Research · 28 Aug 2026positive

Zacks Investment Research highlighted the Medical - Outpatient and Home Healthcare industry, noting tailwinds from an aging population and growing telehealth and AI adoption. The report named Aveanna Healthcare Holdings (AVAH) among companies, along with DVA, LFST, and OPCH, that stand to benefit from these trends.

Why it matters — The piece positions AVAH as one of the companies well-placed to benefit from favorable industry tailwinds such as an aging population and rising telehealth and AI adoption.

Aveanna Healthcare Holdings Inc. (AVAH) Hit a 52 Week High, Can the Run Continue?

Zacks Investment Research · 28 Aug 2026positive

Aveanna Healthcare Holdings Inc. has reached a 52-week high in its stock price. The report examines the company's fundamentals to assess whether the upward run can continue.

Why it matters — Reaching a 52-week high signals notable momentum for AVAH, and the fundamental analysis offers insight into whether the company can sustain further gains.

FAQ

Frequently asked questions about AVAH stock

What is the AVAH stock price forecast for 2026-2027?

The 11 Wall Street analysts covering Aveanna Healthcare Holdings, Inc. have a median 12-month price target of $15, with estimates ranging from $8 to $16. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is AVAH stock a buy right now?

Of the 11 analysts covering Aveanna Healthcare Holdings, Inc., 8 rate it a Buy, 3 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Aveanna Healthcare Holdings, Inc. 87 out of 100 across roughly 4,600 US stocks as at 7 Sept 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank AVAH?

As at 7 Sept 2026, Aveanna Healthcare Holdings, Inc. ranks 87 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Momentum (99 of 100).

Will AVAH stock go up?

No one can know that. What the data says: the median 12-month target from 11 analysts implies +6.1% from the last close, and Ticker Nerd's factor model ranks Aveanna Healthcare Holdings, Inc. 87 out of 100 as at 7 Sept 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the AVAH stock forecast for 2030?

No analyst covering Aveanna Healthcare Holdings, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for AVAH are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $8 to $16 over the next 12 months.

How has AVAH stock performed over the past year?

Aveanna Healthcare Holdings, Inc. returned +65.4% over the 12 months to 8 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Aveanna Healthcare Holdings, Inc. do?

Aveanna Healthcare Holdings Inc. is a diversified home care company that provides pediatric and adult healthcare services across the United States.

What is the latest news on AVAH?

The most recent item we track (Seeking Alpha, 8 Sept 2026): "Stock Picks From Seeking Alpha's August 2026 New Analysts". Seeking Alpha welcomed 25 new analysts in August 2026 and showcased their stock picks and investment strategies, with ratings ranging from Strong Sell to Strong Buy. Bullish theses were presented for CTO Realty, Allogene Therapeutics, NanoXplore, Modine, and 3i Group; Aveanna Healthcare Holdings is not mentioned.

Company

About Aveanna Healthcare Holdings, Inc.

Aveanna Healthcare Holdings Inc. is a diversified home care company that provides pediatric and adult healthcare services across the United States. Aveanna Healthcare Holdings Inc. focuses on care delivered in the home and in community-based settings, serving medically complex and chronically ill patients through private duty nursing, home health, hospice, therapy, rehabilitation, and related support services. The company also offers enteral nutrition and other medical products for patients with specialized care needs. Its services are organized across Private Duty Services, Home Health & Hospice, and Medical Solutions, allowing it to address a broad range of clinical and non-clinical needs for newborns, children, adults, and seniors. Headquartered in Atlanta, Georgia, Aveanna Healthcare Holdings Inc. plays a significant role in the U.S. healthcare services market by helping patients receive coordinated care outside traditional institutional settings.

CEO Mr. Jeffrey S. Shaner · 3,500 employees · United States · https://www.aveanna.com